Pulse Biosciences, Inc.
PLSE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$53,585 | -$42,210 | -$58,505 | -$63,660 |
| Dep. & Amort. | $1,178 | $1,207 | $1,355 | $1,146 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $13,586 | $7,181 | $5,191 | $14,601 |
| Change in WC | $2,472 | $768 | -$3,716 | -$6,197 |
| Other Non-Cash | $6 | $13 | $8,662 | $13 |
| Operating Cash Flow | -$36,343 | -$33,041 | -$47,013 | -$54,097 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$125 | -$121 | -$401 | -$437 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $8,000 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$125 | -$121 | -$401 | $7,563 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $65,000 | $407 |
| Stock Issued | $59,649 | $16,394 | $14,864 | $56,697 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $50,492 | -$6 | $75 | $5,581 |
| Financing Cash Flow | $110,141 | $16,388 | $79,939 | $62,685 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $73,673 | -$16,774 | $32,525 | $16,151 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $44,365 | $61,139 | $28,614 | $12,463 |
| End Cash | $118,038 | $44,365 | $61,139 | $28,614 |
| Free Cash Flow | -$36,468 | -$33,162 | -$47,414 | -$54,534 |